BIOA
NASDAQ HealthcareBioAge Labs, Inc. - Common Stock
Drug Manufacturers - Specialty & Generic
📊 Market Data
| Price | $19.89 |
|---|---|
| Volume | 451,157 |
| Market Cap | 830.25M |
| RSI (14-Day) | 46.1 |
| 200-Day MA | $9.53 |
| 50-Day MA | $19.27 |
| 52-Week High | $24.00 |
| 52-Week Low | $2.88 |
| P/E Ratio | 1.46 |
| Forward P/E | -7.66 |
| Price / Book | 2.57 |
🎯 Investment Strategy Scores
How BIOA scores across each investment strategy. Higher is better for that strategy's goals.
💰 Dividend Daddy
29/100
High dividend yield + low volatility
🚀 Moon Shot
7/100
High growth potential (high beta + oversold)
🔪 Falling Knife
4/100
Contrarian plays (oversold + below moving average)
🎈 Over-Hyped
65/100
Overbought stocks (potential short candidates)
🐋 Institutional Whale
22/100
Large-cap, institutional-quality stocks
Find BIOA in your text
Paste any text on the homepage — the tool will extract BIOA and other hidden tickers.
Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.